Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
作者:
主题词
生物碱类(Alkaloids);吖辛因类(Azocines);结合部位(Binding Sites);环蛇毒素类(Bungarotoxins);细胞系, 肿瘤(Cell Line, Tumor);细胞膜(Cell Membrane);剂量效应关系, 药物(Dose-Response Relationship, Drug);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);膜电位(Membrane Potentials);神经组织蛋白质类(Nerve Tissue Proteins);神经母细胞瘤(Neuroblastoma);神经元(Neurons);尼古丁(Nicotine);烟碱激动剂(Nicotinic Agonists);烟碱拮抗剂(Nicotinic Antagonists);蛋白质结构, 四级(Protein Structure, Quaternary);蛋白质转运(Protein Transport);吡啶类(Pyridines);喹嗪类(Quinolizines);受体, 烟碱(Receptors, Nicotinic);亚细胞部分(Subcellular Fractions);时间因素(Time Factors);增量调节(Up-Regulation)
DOI
10.1038/sj.bjp.0706434
PMID
16273122
发布时间
2018-11-13
- 浏览18

British journal of pharmacology
1096-109页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文